Evidence map›Paper›PMID 38548834›Full record

ArticleScientific reports2024

Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.

Ricardo Sánchez, Sara Dorado, Yanira Ruíz-Heredia, Alejandro Martín-Muñoz, Juan Manuel Rosa-Rosa, Jordi Ribera, Olga García, Ana Jimenez-Ubieto, Gonzalo Carreño-Tarragona, María Linares and 37 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors at 20 institutions in 2 countries.

Ricardo SánchezHematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain. ricardsanchez.hdoc@gmail.com.
Sara DoradoAltum Sequencing Co., Madrid, Spain.
Yanira Ruíz-HerediaAltum Sequencing Co., Madrid, Spain.
Alejandro Martín-MuñozAltum Sequencing Co., Madrid, Spain.
Juan Manuel Rosa-RosaInstituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.
Jordi RiberaHematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
Olga GarcíaHematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
Ana Jimenez-UbietoHematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain.
Gonzalo Carreño-TarragonaHematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain.
María LinaresHematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain.
Laura RufiánInstituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.
Alexandra JuárezHematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain.
Jaime CarrilloAltum Sequencing Co., Madrid, Spain.
María José EspinoHematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain.
Mercedes CáceresHematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain.
Sara ExpósitoLaboratory of Neurophysiology and Synaptic Plasticity, Instituto Cajal, CSIC, Madrid, Spain.
Beatriz CuevasHospital Universitario de Burgos, Burgos, Spain.
Raúl VanegasHospital General Universitario de Ciudad Real, Ciudad Real, Spain.
Luis Felipe CasadoHospital Virgen de la Salud, Toledo, Spain.
Anna TorrentHematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
Lurdes ZamoraHematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
Santiago MercadalHematology Department, ICO-Hospital Duran i Reynals (Bellvitge), Barcelona, Spain.
Rosa CollHematology Department, ICO-Hospital Dr. Josep Trueta, Girona, Spain.
Marta CerveraHematology Department, ICO-Hospital Universitari Joan XXIII, Tarragona, Spain.
Mireia MorgadesHematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
José Ángel Hernández-RivasHospital Universitario Infanta Leonor, Madrid, Spain.
Pilar BravoHospital Universitario de Fuenlabrada, Fuenlabrada (Madrid), Spain.
Cristina SeríHospital Central de la Defensa Gómez Ulla, Madrid, Spain.
Eduardo AnguitaHospital Clínico San Carlos, Department of Medicine, UCM, Madrid, Spain.
Eva BarragánHospital Universitario y Politécnico La Fe, Valencia, Spain.
Claudia SargasHospital Universitario y Politécnico La Fe, Valencia, Spain.
Francisca Ferrer-MarínHospital Universitario Morales-Meseguer, IMIB-Arrixaca, CIBERER, UCAM, Murcia, Spain.
Jorge Sánchez-CaleroHospital Universitario de Móstoles, Móstoles (Madrid), Spain.
Julián SevillaHospital Universitario Niño Jesús, Madrid, Spain.
Elena RuízHospital del Tajo, Aranjuez (Madrid), Spain.
Lucía VillalónHospital Universitario Fundación Alcorcón, Alcorcón (Madrid), Spain.
María Del Mar HerráezHospital Santa Bárbara, Puertollano, Ciudad Real, Spain.
Rosalía RiazaHospital Universitario Severo Ochoa, Leganés, Madrid, Spain.
Elena MagroHospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Juan Luis SteegmanHospital Universitario La Princesa, Madrid, Spain.
Chongwu WangHosea Precision Medical Technology Co., Ltd., Weihai, Shangdong, China.
Paula de ToledoComputer Science and Engineering Department, Carlos III University, Madrid, Spain.
Valentín García-GutiérrezHospital Universitario Ramón y Cajal, Instituto de Investigación IRYCIS, Madrid, Spain.
Rosa AyalaHematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain.
Josep-Maria RiberaHematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
Santiago Barrio *Hematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain.
Joaquín Martínez-López *Hematology Department, Hospital UniversitarioHospital Universitario 12 Octubre, Madrid, Spain. jmarti01@med.ucm.es.
Universitat Autònoma de Barcelona · ESResearch Institute Hospital 12 de Octubre · ESHospital Universitario 12 De Octubre · ESHospital Universitari i Politècnic La Fe · ESSpanish National Cancer Research Centre · ESUniversidad Carlos III de Madrid · ESAltran (France) · FRConsejo Superior de Investigaciones Científicas · ESDuran i Reynals Hospital · ESHospital Central de la Defensa Gómez Ulla · ESHospital Clínico San Carlos · ESHospital General Universitario de Ciudad Real · ESHospital General Universitario Morales Meseguer · ESHospital Infantil Universitario Niño Jesús · ESHospital Universitari de Girona Doctor Josep Trueta · ESHospital Universitari Joan XXIII de Tarragona · ESHospital Universitario de Burgos · ESHospital Universitario de Fuenlabrada · ESHospital Universitario de La Princesa · ESHospital Universitario del Tajo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38548834
PMCPMC10978874
OpenAlexW4393256482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.